Lupin has informed that it enclosed a Press Release as regards, launch of authorized generic version of PENNSAID (Diclofenac Sodium Topical Solution), 2% w/w of Horizon Pharma Therapeutics.
The above information is a part of company’s filings submitted to BSE.